INTRODUCTION
"Man may be the captain of his fate, but he is also the victim of his blood sugar" said by Dr. Wilfred Oakley 1 .
The prevalence of diabetes in 21 st century is increasing due to diet changes, aging, urbanization, and increasing prevalence of obesity and physical inactivity. King et al., 1998 predicted a rise in global diabetes prevalence to 5.4% of the world population by the year 2025 (27% increase in developed countries and 48% increase in developing countries) 2 . In 2000, there were 171 millions of people having diabetes in the world; 2006 was 246 million people. It was estimated that in 2025, there would be 380-399 million people having diabetes 3 . According to an estimate of International Diabetes Federation comparative prevalence of Diabetes during 2007 is 8.0 % and likely to increase to 7.3% by 2025. Number of people with diabetes is 246 million (with 46% of all those affected in the 40-59 age group) and likely to increase to 380 million by 2025 4 . The World Health Organization believes that the 21 st century is the time of endocrine diseases and metabolic disorders, for example, diabetes. In over the world, people have to spend 232 billion to 430 billion USD for diabetes treatments and prevention. Diabetes reduces 5-10 years of human life expectancy. In 2014, the World Health Organization indicates global prevalence of diabetes was estimated to be 9% among adults aged 18+ years and it will be the 7th leading cause of death in 2030 [5] [6] [7] .
Diabetes is a metabolic disorder caused by many reasons. It is characterized by chronic hyperglycemia and metabolic disorders of sugar, protein, fat caused by the deficiency of insulin secretion, the insulin activities, or both. Pathophysiology of type 2 and 1 Diabetes Mellitus is explained in the Fig. 1 and Fig. 2 Pharmaceutical marketing, sometimes called medico-marketing or pharma marketing in some countries is the business of advertising or otherwise promoting the sale of pharmaceuticals or drugs [9] . Pharmaceutical detailing is a marketing technique used by pharmaceutical companies to educate a physician about a vendor's products in hopes that the physician will prescribe the company's products more often. Although this practice is controversial, many drug companies spend billions of dollars a year on this legal tactic. In the United States, marketing and distribution of pharmaceuticals is regulated by the Federal Food, Drug, and Cosmetic Act and the Prescription Drug Marketing Act, respectively. Food and Drug Administration (FDA) regulations require all prescription drug promotion to be truthful and not misleading, based on "substantial evidence or substantial clinical experience", to provide a "fair balance" between the risks and benefits of the promoted drug, and to maintain consistency with labeling approved by the FDA. The FDA Office of Prescription Drug Promotion enforces these requirements 9 . It was long believed that since physicians made the selection of drugs, mass marketing was a waste of resources; specific advertisement targeting the medical profession were thought to be cheaper and just as effective. This would involve advertisement in professional journals and visits by sales staff to physician's offices and hospitals. An important part of these efforts was marketing to medical students 10 . On the basis of this background, we made pharmaceutical marketing investigation of Metformin and its combinations used for Diabetes Mellitus in Moradabad, Rampur, Bareilly and Meerut districts of U.P. (West).
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It was long believed that since physicians made the selection of drugs, mass marketing was a waste of resources; specific advertisement targeting the medical profession were thought to be cheaper and just as effective. This would involve advertisement in professional journals and visits by sales staff to physician's offices and hospitals. An important part of these efforts was marketing to medical students 10 . On the basis of this background, we made pharmaceutical marketing investigation of Metformin and its combinations used for Diabetes Mellitus in Moradabad, Rampur, Bareilly and Meerut districts of U.P. (West).
MATERIALS AND METHODS
This study was depended on a cross-sectional survey design and was conducted by administering a validated questionnaire to physicians and pharmacist on medical store of Moradabad, Rampur, Bareilly and Meerut districts of U.P. (West) on metformin and its combination drugs. Since this study was carried out during April 2015-April 2016, the sample size consisted of 10 Physicians and 10 pharmacist incharge of medical store in the districts (Moradabad, Rampur, Bareilly, Meerut) of U.P.(West) region which will tend to reflect the population size. Both physician as well as pharmacist was informed with the objectives of the study, and they were considered consented to participate in the survey.
Study Instrument:
A questionnaire (Table 1 ) was designed to collect information on Diabetes mellitus from the physicians. Another questionnaire (Table 2 ) was prepared for collecting information from pharmacists on medical stores. Both questionnaires were initially validated by two senior faculty members for content before data collection.
RESULTS AND DISCUSSION

Physician Opinion:
The objective of the study was to conduct and analyze a survey regarding the status of diabetes mellitus-2 among the people of various districts of U.P. west region of India.
Being diagnosed with diabetes is a major life stress and therefore it requires dealing with psychological challenges (grief, denial, anxiety, depression, shame and guilt). Various aspects of life associated diabetes that may affect quality of life include:
 The never-ending demands of diabetes care, such as eating carefully, exercising, monitoring blood glucose, and scheduling and planning
 Symptoms of low or very high blood glucose  Fears about or the reality of complications
The specific things each person needs to feel satisfied and happy are unique to him or her. Still, there are some things most people would agree are important. Your quality of life is your own sense of how satisfied and happy you are with your life in general and your life with diabetes in particular. Many diabetes health care professionals are trained to help their patients adjust treatment regimens to ease the burden of diabetes management while maintaining good blood glucose control and good health. These providers may also be able to help you improve your day-to-day diabetes coping skills.
The data obtained after conducting the survey was drastically modified in comparison to the survey reported by Phool et al., (2013) 11 . In 2013, there were around 46.48% patients having diabetes and in 2015 the numbers are increased to 65.78%. The major outcome was found among the teenagers, 7.45% of teenagers are having type-1 diabetes. After consulting with the medical practitioner, the sole reason of having these disorders was found to be the improper nutritious diet taking and the magnetic effect of junk food, no physical exercise, increased mental stress, environmental toxins, etc, all these factors directly or indirectly linked to insulin resistance (a condition in which the body's muscle, fat, and liver cells do not use insulin effectively to counter the raised blood glucose level and resulted into diabetes).
Physician opinions on the questionnaire about the Diabetes (type-1 & -2) are shown in the Fig. 3 . 65.78% of patients from total OPD patients were found to have diabetes, 49.76% patients are type-2 patients, 7.45% of teenagers were fall in the category of having type-1 diabetes and 8.57% were among the new patients of diabetes. Among various anti-diabetic drugs, Metformin, an oral antidiabetic drug in the biguanide class is the first-line drug of choice for the treatment of type-2 diabetes in particular, in overweight and obese people and those with normal kidney function, while Insulin become the primary drug of choice for type-1 Diabetic patients. 
STUDY LIMITATION
The study gives an idea about the collaboration of Doctor-pharmacist. However, it has some limitations. The sample size is small which provides a brief idea. To increase precision, the sample size may be increased.
CONCLUSION
The global burden of diabetes is increasing worldwide as it is a costly disease for developing economies of the world. While many pharmaceutical companies have successfully deployed a plethora of strategies to target the various customer types, recent business and customer trends are creating new challenges and opportunities for increasing profitability. In the pharmaceutical and healthcare industries, a complex web of decision-makers determines the nature of the transaction (prescription) for which direct customer of pharma industry (doctor) is responsible. Essentially, the end-user (patient) consumes a product and pays the cost. During the process of task we have extracted out that Diabetes Mellitus found to be an epidemic disease among the population of India. Glyciphage, Melmet And Obimet were the brands of the Metformin only, Metformin: Glimepiride, Metformin: Glimepiride: Voglibose and Metformin: Gliclazide, respectively categories which were in highest sale in the area of interest.
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